Literature DB >> 22911184

Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.

Annika Waldmann1, Sandra Nolte, Alan C Geller, Alexander Katalinic, Martin A Weinstock, Beate Volkmer, Ruediger Greinert, Eckhard W Breitbart.   

Abstract

OBJECTIVE: To explore the frequency of excisions and yields of histopathologically confirmed skin cancer.
DESIGN: A population-based skin cancer screening intervention (the SCREEN project) in the German state of Schleswig-Holstein (July 1, 2003, to June 30, 2004).
SETTING: Physician offices. Participants could choose between nondermatologist physicians and dermatologists for their initial whole-body skin examination. All screening physicians received a mandatory 8-hour training course. PARTICIPANTS Inhabitants of Schleswig-Holstein 20 years or older with statutory health insurance (N = 360,288). MAIN OUTCOME MEASURES: Frequency of excisions and yields of malignant skin tumors (malignant melanomas [MMs], basal cell carcinomas [BCCs], and squamous cell carcinomas [SCCs]), stratified by sex and age.
RESULTS: Overall, 15,983 excisions were performed (1 of 23 screenees). A total of 3103 malignant skin tumors were diagnosed in 2911 persons: 585 MMs, 1961 BCCs, 392 SCCs, and 165 other malignant skin tumors. Overall, 116 persons (3103 of 360,288) had to be screened to find 1 malignant tumor, with 1 of 620 for MM, 1 of 184 for BCC, and 1 of 920 for SCC. Twenty excisions were performed to find 1 melanoma in men 65 years and older, but more than 50 excisions were required to find 1 melanoma in men aged between 20 and 49 years.
CONCLUSIONS: The results of SCREEN suggest a high yield of malignant skin tumors in a large-scale population-based screening project. We found that a high number of excisions was performed in the youngest screenees with an associated low yield, suggesting a need in screener training to emphasize a more conservative attitude toward excisions in young screenees.

Entities:  

Mesh:

Year:  2012        PMID: 22911184     DOI: 10.1001/archdermatol.2012.893

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  20 in total

1.  [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].

Authors:  C Rose
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

2.  United States Preventive Services Task Force Overstates Cosmetic Harms of Skin Cancer Screening.

Authors:  Joseph F Sobanko; Kimberly Shao; Rebecca L Pearl; Sancy Leachman
Journal:  J Clin Aesthet Dermatol       Date:  2018-04-01

3.  Estimating the cost of skin cancer detection by dermatology providers in a large health care system.

Authors:  Martha Matsumoto; Aaron Secrest; Alyce Anderson; Melissa I Saul; Jonhan Ho; John M Kirkwood; Laura K Ferris
Journal:  J Am Acad Dermatol       Date:  2017-11-24       Impact factor: 11.527

4.  [Much better and incentive for the future].

Authors:  A Blum
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

5.  Screening for Melanoma in Men: a Cost-Effectiveness Analysis.

Authors:  Adewole S Adamson; Jamie A Jarmul; Michael P Pignone
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

6.  [Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].

Authors:  J Hübner; M R Noftz; M Schnoor; A Katalinic
Journal:  Internist (Berl)       Date:  2014-10       Impact factor: 0.743

7.  [Tumors of the scalp: special aspects of selected examples].

Authors:  C Rose
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

8.  [Skin cancer screening in Germany : The situation in 2014 with suggestions for the future].

Authors:  A Blum; J Kreusch; W Stolz; H Haenssle
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

Review 9.  [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].

Authors:  C Rose
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 10.  Advances in Prevention and Surveillance of Cutaneous Malignancies.

Authors:  Megan H Trager; Dawn Queen; Faramarz H Samie; Richard D Carvajal; David R Bickers; Larisa J Geskin
Journal:  Am J Med       Date:  2019-11-09       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.